Estados financieros detallados de Crinetics Pharmaceuticals, Inc. (CRNX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Crinetics Pharmaceuticals, Inc. registró ingresos de $7.7M en el último ejercicio fiscal, con un CAGR de 5 años del 155.3%.
Márgenes de los últimos 12 meses: margen bruto 99.2%, margen operativo -13.0%, margen neto -11.9%.
Al precio actual de $84.95, CRNX presenta beneficios negativos (P/E no significativo) y un ROE del -44.22%. La capitalización bursátil es de $9.0B.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $589000 | $2.0M | $2.4M | $1.2M | $71000 | $1.1M | $4.7M | $4.0M | $1.0M | $7.7M |
| Coste de Ventas | $5.1M | $9.2M | $24.5M | $1.1M | $57.0M | 0 | 0 | 0 | 0 | $1.1M |
| Beneficio Bruto | -$4.5M | -$7.2M | -$22.1M | $80000 | -$56.9M | $1.1M | $4.7M | $4.0M | $1.0M | $6.6M |
| I+D | $5.1M | $9.2M | $24.5M | $41.5M | $57.6M | $84.3M | $130.2M | $168.5M | $240.2M | $332.1M |
| Generales y Administrativos | $1.5M | $1.9M | $6.7M | $13.5M | $18.0M | $24.5M | $42.4M | $58.1M | $99.7M | $191.3M |
| Gastos Operativos | $6.0M | $9.1M | $28.7M | $53.8M | $18.0M | $108.8M | $172.6M | $226.6M | $339.9M | $523.4M |
| Beneficio Operativo | -$6.0M | -$9.1M | -$28.7M | -$53.8M | -$75.0M | -$107.7M | -$167.9M | -$222.6M | -$338.9M | -$516.8M |
| EBITDA | -$6.0M | -$9.0M | -$28.2M | -$49.3M | -$74.0M | -$106.7M | -$162.9M | -$213.4M | -$295.6M | -$461.2M |
| Gastos por Intereses | $11000 | $8000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$6.0M | -$9.2M | -$27.1M | -$50.4M | -$73.8M | -$107.6M | -$163.9M | -$214.5M | -$298.4M | -$465.1M |
| Impuestos | $10000 | -$40000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $180000 |
| Beneficio Neto | -$6.0M | -$9.2M | -$27.1M | -$49.5M | -$73.8M | -$107.6M | -$163.9M | -$214.5M | -$298.4M | -$465.3M |
| BPA | $-0.43 | $-0.66 | $-2.23 | $-2.05 | $-2.42 | $-2.80 | $-3.15 | $-3.69 | $-3.69 | $-4.95 |
| BPA Diluido | $-0.43 | $-0.66 | $-2.23 | $-2.05 | $-2.42 | $-2.80 | $-3.15 | $-3.69 | $-3.69 | $-4.95 |
| Acciones en Circulación (Diluidas) | $13.9M | $13.9M | $12.1M | $24.2M | $30.4M | $38.4M | $52.0M | $58.1M | $80.8M | $94.1M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $143000 | $6.2M | $10.7M | $25.1M |
| Beneficio Bruto | $143000 | $6.2M | $10.5M | $25.0M |
| Beneficio Operativo | -$142.6M | -$133.7M | -$140.4M | -$132.5M |
| EBITDA | -$129.1M | -$121.6M | -$126.7M | -$131.4M |
| Beneficio Neto | -$130.1M | -$122.8M | -$127.8M | -$120.9M |
| BPA | $-1.38 | $-1.30 | $-1.23 | $-1.14 |
| BPA Diluido | $-1.38 | $-1.30 | $-1.23 | $-1.14 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $12.2M | $14.2M | $45.0M | $40.3M | $93.1M | $200.7M | $32.7M | $54.9M | $264.5M | $101.5M |
| Inversiones a Corto | 0 | 0 | $118.9M | $78.1M | $77.8M | $133.0M | $301.8M | $503.7M | $1.09B | $926.4M |
| Cuentas por Cobrar | $72000 | $734000 | 0 | $1.4M | $1.8M | $2.0M | $2.4M | $9.4M | $8.5M | $592000 |
| Inventario | $98000 | $141000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $2.0M |
| Activos Corrientes | $12.4M | $15.2M | $166.7M | $123.3M | $177.5M | $344.7M | $345.2M | $574.2M | $1.38B | $1.05B |
| Inmovilizado Material | $224000 | $400000 | $4.2M | $6.5M | $5.4M | $4.7M | $5.0M | $57.4M | $55.6M | $54.8M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $12.6M | $15.6M | $171.4M | $130.4M | $183.4M | $351.0M | $352.2M | $635.4M | $1.43B | $1.14B |
| Cuentas por Pagar | $340000 | $403000 | $1.5M | $2.7M | $3.5M | $4.3M | $6.9M | $6.5M | $5.9M | $22.6M |
| Deuda a Corto | $49000 | 0 | 0 | $724000 | 0 | $939000 | $1.1M | $4.2M | 0 | $6.5M |
| Pasivos Corrientes | $890000 | $897000 | $7.9M | $8.3M | $10.5M | $16.0M | $27.7M | $43.9M | $59.7M | $85.1M |
| Deuda a Largo | $163000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $18.8M | $30.6M | $11.2M | $13.2M | $14.5M | $19.1M | $35.8M | $96.2M | $109.8M | $143.4M |
| Reservas | -$7.1M | -$16.3M | -$43.4M | -$93.8M | -$167.6M | -$275.3M | -$439.2M | -$653.7M | -$952.1M | -$1.42B |
| Patrimonio Neto | -$6.2M | -$15.0M | -$43.4M | $117.1M | $168.9M | $331.9M | $316.3M | $539.1M | $1.32B | $992.1M |
| Deuda Total | $212000 | 0 | 0 | $5.6M | $4.0M | $4.0M | $3.1M | $51.7M | $51.7M | $48.5M |
| Deuda Neta | -$11.9M | -$14.2M | -$163.9M | -$112.8M | -$166.9M | -$329.7M | -$331.4M | -$506.8M | -$1.30B | -$979.3M |
| Capital Circulante | $11.5M | $14.3M | $158.8M | $115.0M | $167.0M | $328.7M | $317.5M | $530.2M | $1.32B | $963.3M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $110.9M | $101.5M | $114.3M | $55.5M |
| Activos Totales | $1.20B | $1.14B | $1.40B | $1.32B |
| Pasivos Totales | $123.9M | $143.4M | $120.7M | $129.9M |
| Patrimonio Neto | $1.07B | $992.1M | $1.28B | $1.19B |
| Deuda Total | $49.1M | $48.5M | $47.9M | $47.2M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$6.0M | -$9.2M | -$27.1M | -$50.4M | -$73.8M | -$107.6M | -$163.9M | -$214.5M | -$298.4M | -$465.3M |
| Amortizaciones | $92000 | $128000 | $471000 | $887000 | $948000 | $922000 | $983000 | $1.1M | $2.8M | $3.9M |
| Compensación en Acciones | $270000 | $271000 | $2.3M | $6.3M | $10.4M | $17.4M | $28.3M | $40.9M | $69.4M | $91.0M |
| Cambio en Capital Circulante | $189000 | -$721000 | $5.3M | -$2.1M | $376000 | $1.1M | $18.6M | $8.0M | $11.6M | $4.8M |
| Flujo de Caja Operativo | -$5.5M | -$9.5M | -$19.5M | -$46.4M | -$62.0M | -$88.6M | -$115.2M | -$166.3M | -$226.0M | -$377.9M |
| Inversiones (CapEx) | -$190000 | -$304000 | -$1.1M | -$492000 | -$186000 | -$436000 | -$1.7M | -$4.7M | -$3.8M | -$5.8M |
| Adquisiciones | 0 | 0 | 0 | -$1.2M | -$227000 | $422000 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | -$5000 | 0 | 0 | -$59000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$5.7M | -$9.8M | -$20.5M | -$46.9M | -$62.2M | -$89.0M | -$116.9M | -$171.0M | -$229.8M | -$383.7M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$110.7M | -$92.9M | -$124.7M | -$94.2M |
| Inversiones (CapEx) | -$863000 | -$458000 | -$820000 | -$521000 |
| Flujo de Caja Libre | -$111.6M | -$93.4M | -$125.5M | -$94.7M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $22.7M | $21.7M | $29.7M | $24.9M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +247.2% | +18.7% | -50.9% | -94.0% | +1418.3% | +339.4% | -15.3% | -74.1% | +640.7% |
| Crecimiento Beneficio Neto (anual) | | -52.1% | -196.1% | -82.7% | -49.0% | -45.8% | -52.3% | -30.9% | -39.1% | -55.9% |
| Crecimiento BPA (anual) | | -53.5% | -237.9% | +8.1% | -18.0% | -15.7% | -12.5% | -17.1% | +0.0% | -34.1% |
| Cambio en Acciones (anual) | | +0.0% | -12.5% | +99.1% | +25.9% | +26.2% | +35.2% | +11.7% | +39.1% | +16.4% |
| Crecimiento FCF (anual) | | -72.9% | -109.7% | -128.4% | -32.7% | -43.1% | -31.3% | -46.3% | -34.4% | -67.0% |
| Margen Bruto | -765.9% | -351.5% | -908.2% | 6.7% | -80178.9% | 100.0% | 100.0% | 100.0% | 100.0% | 86.0% |
| Margen Operativo | -1026.1% | -446.3% | -1182.5% | -4512.3% | -105567.6% | -9990.9% | -3544.1% | -5547.2% | -32613.5% | -6714.8% |
| Margen EBITDA | -1010.5% | -440.0% | -1163.1% | -4133.2% | -104232.4% | -9899.7% | -3439.6% | -5318.5% | -28452.6% | -5993.3% |
| Margen Neto | -1021.9% | -447.8% | -1116.8% | -4152.1% | -103960.6% | -9985.3% | -3460.4% | -5345.9% | -28720.7% | -6046.2% |
| Margen FCF | -960.6% | -478.4% | -845.1% | -3929.0% | -87623.9% | -8258.3% | -2467.0% | -4261.0% | -22118.8% | -4985.5% |
| Tasa Impositiva Efectiva | -0.2% | 0.4% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.41 | $-0.70 | $-1.69 | $-1.94 | $-2.04 | $-2.32 | $-2.25 | $-2.94 | $-2.84 | $-4.08 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $13.9M | $13.9M | $12.1M | $24.2M | $30.4M | $38.4M | $52.0M | $58.1M | $80.8M | $94.1M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -44.22% |
| Rentabilidad sobre capital invertido | -43.98% |
| Rentabilidad sobre activos | -37.95% |
| Margen bruto | 99.16% |
| Margen operativo | -1302.52% |
| Margen neto | -1189.88% |
Salud financiera
| Deuda / Patrimonio | 0.04 |
| Ratio corriente | 15.57 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 16.09 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -57.00 | -37.14 | -13.45 | -12.24 | -5.83 | -10.15 | -5.81 | -9.64 | -13.86 | -9.40 |
| P/VC | -54.83 | -22.64 | -8.39 | 5.18 | 2.54 | 3.29 | 3.01 | 3.83 | 3.12 | 4.41 |
| P/V | 577.51 | 166.33 | 149.97 | 508.42 | 6051.00 | 1012.96 | 200.82 | 514.87 | 3975.39 | 568.91 |
| Margen Bruto | -765.9% | -351.5% | -908.2% | 6.7% | -80178.9% | 100.0% | 100.0% | 100.0% | 100.0% | 86.0% |
| Margen Operativo | -1026.1% | -446.3% | -1182.5% | -4512.3% | -105567.6% | -9990.9% | -3544.1% | -5547.2% | -32613.5% | -6714.8% |
| Margen Neto | -1021.9% | -447.8% | -1116.8% | -4152.1% | -103960.6% | -9985.3% | -3460.4% | -5345.9% | -28720.7% | -6046.2% |